Revenue for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current revenue (TTM) is $5.40B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$5.40B
YoY change
+9.8%
5Y CAGR
+11.7%
Peak year (2025)
$5.15B
Cumulative revenue
$45.97B
Revenue history chart for ResMed (RMD) from 1993 to 2025
Revenue history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $5.15B | +9.8% | ||
| 2024 | $4.69B | +10.9% | ||
| 2023 | $4.22B | +18.0% | ||
| 2022 | $3.58B | +11.9% | ||
| 2021 | $3.20B | +8.1% | ||
| 2020 | $2.96B | +13.4% | ||
| 2019 | $2.61B | +11.4% | ||
| 2018 | $2.34B | +13.2% | ||
| 2017 | $2.07B | +12.4% | ||
| 2016 | $1.84B | +9.5% | ||
| 2015 | $1.68B | +8.0% | ||
| 2014 | $1.55B | +2.7% | ||
| 2013 | $1.51B | +10.7% | ||
| 2012 | $1.37B | +10.1% | ||
| 2011 | $1.24B | +13.8% | ||
| 2010 | $1.09B | +18.6% | ||
| 2009 | $920.74M | +10.2% | ||
| 2008 | $835.40M | +16.6% | ||
| 2007 | $716.33M | +18.0% | ||
| 2006 | $607.00M | +42.7% | ||
| 2005 | $425.50M | +25.4% | ||
| 2004 | $339.34M | +24.0% | ||
| 2003 | $273.57M | +34.1% | ||
| 2002 | $204.08M | +31.5% | ||
| 2001 | $155.16M | +34.2% | ||
| 2000 | $115.61M | +30.5% | ||
| 1999 | $88.60M | +33.2% | ||
| 1998 | $66.50M | +35.2% | ||
| 1997 | $49.20M | +42.2% | ||
| 1996 | $34.60M | +47.2% | ||
| 1995 | $23.50M | +69.1% | ||
| 1994 | $13.90M | +80.5% | ||
| 1993 | $7.70M | — |
Revenue values are taken from ResMed's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, ResMed (RMD) reported revenue of $5.15B – grew 9.8% year-over-year.
ResMed revenue has grown for 32 consecutive years, with a +11.7% compound annual growth rate over 2020–2025 (5 years).
$5.15B stands as the all-time-high annual revenue, posted in 2025, against a low of $7.70M during 1993.
Among 8 Healthcare peers, ResMed (RMD) ranks 9th; the peer median for revenue is $65.09B.
ResMed Revenue by Year
ResMed Revenue 2025: $5.15B
ResMed revenue in 2025 was $5.15B, grew 9.8% from 2024. This figure represents the highest annual value in the available history.
ResMed Revenue 2024: $4.69B
ResMed revenue in 2024 was $4.69B, grew 10.9% from 2023.
ResMed Revenue 2023: $4.22B
ResMed revenue in 2023 was $4.22B, grew 18.0% from 2022.
ResMed Revenue 2022: $3.58B
ResMed revenue in 2022 was $3.58B, grew 11.9% from 2021.
ResMed Revenue 2021: $3.20B
ResMed revenue in 2021 was $3.20B.
See more financial history for ResMed (RMD).
Sector peers — Revenue
Companies in the same sector as ResMed, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is ResMed's revenue?
- Latest reported revenue for ResMed (RMD) is $5.40B (period ending December 31, 2025).
How has ResMed revenue changed year-over-year?
- ResMed (RMD) revenue changed +9.8% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed revenue?
- ResMed (RMD) revenue compound annual growth rate is +11.7% over the most recent 5 years available.
When did ResMed revenue hit its highest annual value?
- ResMed revenue reached its highest annual value of $5.15B in 2025.
What was ResMed revenue in 2024?
- ResMed (RMD) revenue in 2024 was $4.69B.
What was ResMed revenue in 2025?
- ResMed (RMD) revenue in 2025 was $5.15B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.